Beyond Air Inc (XAIR) Stock Price, Quote & News

Company Profile

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiol...

Industry: Medical Devices

Sector: Healthcare

Phone: 516 665 8200

Website: www.beyondair.net

Address:

900 Stewart Avenue, Suite 301, Garden City, United States

VernCapital Jun. 26 at 3:13 PM

$XAIR so Lisi probably got a nice little $1M partying handshake 🙄

0 · Reply

EarningsInsider Jun. 26 at 12:47 PM

https://www.marketbeat.com/earnings/reports/2026-6-26-beyond-air-inc-stock/ $XAIR Beyond Air Earnings Transcript

0 · Reply

StocktwitsEarnings Jun. 26 at 12:32 PM

$XAIR Q4 '26 Earnings Results & Recap Beyond Air announced revenue guidance of $8 million for calendar year 2026, representing 15% growth, and $16-$18 million for calendar year 2027, indicating more than 110% growth.

0 · Reply

MasterOfMyDomains Jun. 26 at 11:09 AM

$XAIR well, that didn't last long

0 · Reply

npcpaperboy Jun. 26 at 1:03 AM

$XAIR earnings 8am

0 · Reply

rapidtrades Jun. 25 at 7:00 PM

$XAIR we going to skyrocket ! 🚀

1 · Reply

rapidtrades Jun. 25 at 6:58 PM

$XAIR ok added a small position to test the waters

0 · Reply

Say_Whaaaat Jun. 23 at 8:15 PM

$XAIR think the shorts are closing before the split not wanting to be caught in a micro float? I wonder if the price runs up post split, seeing as the float will be well below a million shares....

1 · Reply

Jeffartist Jun. 23 at 10:09 AM

$WKSP ☝️$AZTR $YMT $XAIR So, today symbol change American Ecofuel $AEFI !

0 · Reply

VernCapital Jun. 23 at 3:58 AM

$XAIR I said before the first split it was disaster for pre-split investors. Now it’s just like watching a toilet flush in slow motions. Earnings call on a Friday ? They having nothing in the bag for 2026. Lisi departure and new CEO might have been the only card they could play to ask Nasdaq to allow another R/S

1 · Reply

Beyond Air Earnings Call Transcript: Q4 2026

Jun 26, 2026, 8:00 AM EDT - 12 hours ago

Beyond Air Earnings release: Q4 2026

Jun 26, 2026, 8:00 AM EDT - 12 hours ago

Beyond Air Annual report: Q4 2026

2026-06-26T11:20:47.000Z - 12 hours ago

Beyond Air narrows FY26 revenue view to $8M from $8M-$10M, consensus $8.08M

2026-06-26T11:20:37.000Z - 12 hours ago

Beyond Air sees FY27 revenue $16M-$18M, consensus $12.7M

2026-06-26T11:15:15.000Z - 12 hours ago

Beyond Air reports Q4 EPS (77c) vs. ($1.79) last year

Jun 26, 2026, 7:00 AM EDT - 13 hours ago

Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update

Jun 22, 2026, 4:01 PM EDT - 4 days ago

Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast

Jun 10, 2026, 8:00 AM EDT - 16 days ago

Beyond Air, Inc. Urges Stockholders to Vote “FOR” All Proposals Ahead of the Upcoming Special Meeting

2026-06-01T13:58:00.000Z - 25 days ago

Beyond Air receives Nasdaq hearing panel decision granting continued listing

Jun 1, 2026, 8:00 AM EDT - 25 days ago

Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing

May 5, 2026, 8:00 AM EDT - 7 weeks ago

Beyond Air Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Beyond Air Proxy statement: Proxy filing

2026-04-20T12:58:40.000Z - 2 months ago

Beyond Air’s Beyond Cancer reports updated data from Phase 1 UNO trial

Apr 20, 2026, 8:00 AM EDT - 2 months ago

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

Apr 15, 2026, 8:00 AM EDT - 2 months ago

Beyond Air to Participate in the D. Boral Capital Global Conference 2026

2026-03-26T20:10:58.000Z - 3 months ago

Beyond Air CEO Steve Lisi resigns, Robert Goodman succeeds

2026-03-17T20:45:51.000Z - 3 months ago

Beyond Air subsidiary reports signs of clinical activity from UNO trial

Mar 17, 2026, 4:35 PM EDT - 3 months ago

Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial

Mar 12, 2026, 2:30 PM EDT - 3 months ago

Beyond Air Transcript: Life Sciences Virtual Investor Forum

2026-03-10T11:35:43.000Z - 3 months ago

Beyond Air announces termination of NeuroNOS agreement with XTL

XTLB

2026-02-20T13:08:00.000Z - 4 months ago

Beyond Air announces publication of review article on effects of iNO

Feb 20, 2026, 8:00 AM EST - 4 months ago

Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections

2026-02-19T21:31:02.000Z - 4 months ago

Beyond Air price target lowered to $2 from $6 at JonesResearch

Feb 13, 2026, 8:00 AM EST - 4 months ago

Beyond Air Earnings Call Transcript: Q3 2026

Feb 13, 2026, 8:00 AM EST - 4 months ago

Beyond Air Earnings release: Q3 2026

Feb 13, 2026, 8:00 AM EST - 4 months ago

Beyond Air Quarterly report: Q3 2026

2026-02-13T12:36:07.000Z - 4 months ago

Beyond Air reports Q3 EPS (85c) vs ($2.96) last year

2026-02-13T12:36:01.000Z - 4 months ago

Beyond Air sees FY26 revenue $8M-$10M, consensus $8.28M

Feb 13, 2026, 7:30 AM EST - 4 months ago

Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

Feb 13, 2026, 6:00 AM EST - 4 months ago

Beyond Air Slides: Corporate presentation

2026-01-30T21:10:38.000Z - 5 months ago

Beyond Air files to sell 7.86M shares of common stock for holders

Jan 30, 2026, 7:00 AM EST - 5 months ago

Beyond Air Registration statement: Registration Filing

2026-01-29T21:40:19.000Z - 5 months ago

XTL Biopharmaceuticals provides update on recent developments

XTLB

Jan 27, 2026, 4:05 PM EST - 5 months ago

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

2026-01-20T12:35:20.000Z - 5 months ago

Beyond Air initiated with a Buy at Rodman & Renshaw

Jan 15, 2026, 1:30 PM EST - 5 months ago

Beyond Air Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit

2026-01-14T13:45:25.000Z - 5 months ago

Beyond Air prices 3.93M shares at $1.272 in private placement

Jan 13, 2026, 7:30 AM EST - 5 months ago

XTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Dec 19, 2025, 7:00 AM EST - 6 months ago

Beyond Air Proxy statement: Proxy Filing

Dec 11, 2025, 7:00 AM EST - 7 months ago

Beyond Air Registration statement: Registration Filing

Nov 26, 2025, 4:30 PM EST - 7 months ago

Beyond Air® Announces Transition of Chief Financial Officer

Nov 21, 2025, 7:00 AM EST - 7 months ago

Beyond Air Registration statement: Registration Filing

Nov 10, 2025, 4:30 PM EST - 8 months ago

Beyond Air Earnings Call Transcript: Q2 2026

Nov 10, 2025, 4:30 PM EST - 8 months ago

Beyond Air Quarterly report: Q2 2026

Nov 10, 2025, 4:30 PM EST - 8 months ago

Beyond Air Earnings release: Q2 2026

Nov 10, 2025, 4:05 PM EST - 8 months ago

Beyond Air® Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update

Nov 10, 2025, 7:00 AM EST - 8 months ago

Beyond Air Slides: Corporate presentation

Sep 30, 2025, 8:00 AM EDT - 9 months ago

Beyond Air Registration statement: Registration Filing

Sep 25, 2025, 8:00 AM EDT - 9 months ago

Beyond Air Registration statement: Registration Filing

Sep 22, 2025, 8:00 AM EDT - 9 months ago

Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Sep 8, 2025, 3:55 PM EDT - 10 months ago

Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds

Sep 3, 2025, 8:00 AM EDT - 10 months ago

Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Aug 20, 2025, 8:00 AM EDT - 11 months ago

Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Beyond Air Earnings Call Transcript: Q1 2026

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Beyond Air Earnings release: Q1 2026

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Beyond Air Quarterly report: Q1 2026

Jul 25, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast

Jul 22, 2025, 7:30 AM EDT - 1 year ago

Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.

Jun 17, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings Call Transcript: Q4 2025

Jun 17, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Annual report: Q4 2025

Jun 17, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings release: Q4 2025

Jun 17, 2025, 4:01 PM EDT - 1 year ago

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Jun 16, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH

May 20, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast

May 5, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Apr 21, 2025, 4:05 PM EDT - 1 year ago

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

Apr 15, 2025, 4:05 PM EDT - 1 year ago

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

Apr 9, 2025, 4:05 PM EDT - 1 year ago

Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients' Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

Mar 24, 2025, 4:05 PM EDT - 1 year ago

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

Mar 11, 2025, 7:30 AM EDT - 1 year ago

Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

Feb 10, 2025, 4:30 PM EST - 1 year ago

Beyond Air Earnings Call Transcript: Q3 2025

Feb 10, 2025, 4:30 PM EST - 1 year ago

Beyond Air Quarterly report: Q3 2025

Feb 10, 2025, 4:30 PM EST - 1 year ago

Beyond Air Earnings release: Q3 2025

Feb 10, 2025, 4:05 PM EST - 1 year ago

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

Feb 5, 2025, 9:29 AM EST - 1 year ago

Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

Jan 31, 2025, 7:00 AM EST - 1 year ago

Beyond Air Registration statement: Registration Filing

Jan 27, 2025, 4:05 PM EST - 1 year ago

Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Jan 24, 2025, 9:15 AM EST - 1 year ago

Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia

Jan 13, 2025, 10:30 AM EST - 1 year ago

Beyond Air Transcript: Lytham Partners 2025 Investor Healthcare Summit

Dec 9, 2024, 11:00 AM EST - 1 year ago

National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products

Dec 4, 2024, 4:30 PM EST - 1 year ago

Beyond Air Transcript: Piper Sandler 36th Annual Healthcare Conference

Dec 3, 2024, 4:05 PM EST - 1 year ago

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy

Dec 2, 2024, 7:30 AM EST - 1 year ago

Beyond Air Receives CE Mark in Europe for the LungFit® PH System

Nov 26, 2024, 7:30 AM EST - 1 year ago

NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board

Nov 21, 2024, 7:00 AM EST - 1 year ago

Beyond Air Registration statement: Registration Filing

Nov 14, 2024, 4:05 PM EST - 1 year ago

Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 11, 2024, 4:30 PM EST - 1 year ago

Beyond Air Earnings Call Transcript: Q2 2025

Nov 11, 2024, 4:30 PM EST - 1 year ago

Beyond Air Quarterly report: Q2 2025

Nov 11, 2024, 4:05 PM EST - 1 year ago

Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Oct 29, 2024, 4:22 PM EDT - 1 year ago

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Oct 25, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Registration statement: Registration Filing

Oct 18, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Oct 7, 2024, 7:00 AM EDT - 1 year ago

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 2, 2024, 7:30 AM EDT - 1 year ago

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

Sep 27, 2024, 7:34 AM EDT - 1 year ago

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

Sep 27, 2024, 7:32 AM EDT - 1 year ago

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

Sep 27, 2024, 7:30 AM EDT - 1 year ago

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Sep 23, 2024, 8:00 AM EDT - 1 year ago

Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Aug 20, 2024, 8:00 AM EDT - 2 years ago

Beyond Air Registration statement: Registration Filing

Aug 6, 2024, 4:00 PM EDT - 2 years ago

Beyond Air Quarterly report: Q1 2025

Aug 6, 2024, 4:00 PM EDT - 2 years ago

Beyond Air Earnings release: Q1 2025

Jul 31, 2024, 4:15 PM EDT - 2 years ago

Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia

Jul 23, 2024, 4:05 PM EDT - 2 years ago

Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6

Jul 16, 2024, 4:05 PM EDT - 2 years ago

Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024

Jun 24, 2024, 4:30 PM EDT - 2 years ago

Beyond Air Earnings Call Transcript: Q4 2024

Jun 24, 2024, 4:30 PM EDT - 2 years ago

Beyond Air Earnings release: Q4 2024

Jun 24, 2024, 4:30 PM EDT - 2 years ago

Beyond Air Annual report: Q4 2024

Jun 24, 2024, 4:15 PM EDT - 2 years ago

Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Jun 13, 2024, 4:05 PM EDT - 2 years ago

Beyond Air® Appoints David Webster as Chief Commercial Officer

VernCapital Jun. 26 at 3:13 PM

$XAIR so Lisi probably got a nice little $1M partying handshake 🙄

0 · Reply

EarningsInsider Jun. 26 at 12:47 PM

https://www.marketbeat.com/earnings/reports/2026-6-26-beyond-air-inc-stock/ $XAIR Beyond Air Earnings Transcript

0 · Reply

StocktwitsEarnings Jun. 26 at 12:32 PM

0 · Reply

MasterOfMyDomains Jun. 26 at 11:09 AM

$XAIR well, that didn't last long

0 · Reply

npcpaperboy Jun. 26 at 1:03 AM

$XAIR earnings 8am

0 · Reply

rapidtrades Jun. 25 at 7:00 PM

$XAIR we going to skyrocket ! 🚀

1 · Reply

rapidtrades Jun. 25 at 6:58 PM

$XAIR ok added a small position to test the waters

0 · Reply

Say_Whaaaat Jun. 23 at 8:15 PM

$XAIR think the shorts are closing before the split not wanting to be caught in a micro float? I wonder if the price runs up post split, seeing as the float will be well below a million shares....

1 · Reply

Jeffartist Jun. 23 at 10:09 AM

$WKSP ☝️$AZTR $YMT $XAIR So, today symbol change American Ecofuel $AEFI !

0 · Reply

VernCapital Jun. 23 at 3:58 AM

1 · Reply

Say_Whaaaat Jun. 22 at 9:26 PM

$XAIR the PR bots are dropping the ball, they also filed for the year end ER call. This Friday 6/26/26 at 8:00am.

0 · Reply

Say_Whaaaat Jun. 22 at 8:27 PM

$XAIR welp, another 20:1 split. So for every 1000 shares you had pre first split, you'll now end up with 2, because of course the MM gets the fractions. There will now be only 630k shares in the float.... Twas fun while it lasted!

1 · Reply

DingleberryDandy Jun. 18 at 8:09 PM

$XAIR this board used to be fun. now it's just an unending funeral

2 · Reply

DingleberryDandy Jun. 16 at 7:01 PM

$XAIR new all time low

0 · Reply

uptrend2025 Jun. 12 at 11:34 AM

$XAIR This will be nice to jump back in after RS approval and execution of RS. 👀

1 · Reply

VernCapital Jun. 12 at 12:51 AM

$XAIR oh no..if we don’t approve the reverse split (again) we might lose all our investment. Opposed to losing 99.6% of our investment.

4 · Reply

domarffm Jun. 10 at 12:05 PM

$XAIR Beyond Air, Inc. Urges Stockholders to Vote "FOR" All Proposals Ahead of the Upcoming Special Meeting https://www.beyondair.net/news-events/press-releases?i=167235

0 · Reply

F1ghTorFl1ght Jun. 8 at 4:26 PM

$XAIR tried to invest in something that was doing potential good in the world and will never recoup these losses. The treatment of investors has been criminal.

0 · Reply

VernCapital Jun. 6 at 2:38 PM

$XAIR Things Lisi never disclosed to investors at the time or in subsequent ER calls/filings 1. Software upon launch was out of date and needed upgrading . new machine was outdated before it was launched. 2. Lost transport partner. Essentially lost major portion of potential hospital contracts in US that needed a transport available machine as a requirement. 3. Dropping of cardiac label FDA submission. Was promised as large untapped market. Quietly dropped the submission despite spending months on the application in favour of lungfit2 FDA application. 4. Multiple legal action filings/lawsuits for unfair dismissal or breach of contract. Never once filed under 10k legal pending issues.

3 · Reply

Say_Whaaaat Jun. 5 at 9:49 PM

$XAIR if they do a 10 to 1 split, that means pre both splits, for every 1000 shares you had you'll now how 5! Thanks Lisi!

2 · Reply

Fufat Jun. 1 at 1:27 PM

$XAIR from $4.20 ish high to .45. This is criminal! Why thr steep drop? This has been shorted to high heaven. The company is still moving forward with their products. Nothing really changed other than the old CEO left. We shouldnt be down here but here we are!

1 · Reply

DingleberryDandy Jun. 1 at 12:33 PM

$XAIR not dead yet. they can remain listed for a while longer. looks like a r/s is coming within a month

0 · Reply

Market Cap	6.32M
Revenue (ttm)	3.71M
Net Income (ttm)	-46.63M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,256.87%
Debt to Equity Ratio	2.65

Volume	1,207,000
Avg Vol	334,018
Day's Range	N/A - N/A
Shares Out	13.19M
Stochastic %K	77%
Beta	0.26
Analysts	Sell
Price Target	$2.00